Archive: 25/05/2018
New treatment approved for rare disease PKU
(HealthDay)—Palynziq (pegvaliase-pqpz) has been approved by the U.S. Food and Drug Administration to treat phenylketonuria, commonly called PKU.
May 25, 2018
(HealthDay)—Palynziq (pegvaliase-pqpz) has been approved by the U.S. Food and Drug Administration to treat phenylketonuria, commonly called PKU.
May 25, 2018